Recent news highlights DuPont's Q3 2026 financial performance, strategic outlook updates, and ongoing business developments.

• DuPont reported third quarter 2026 net sales of $1.9 billion, reflecting organic growth and operational improvements [N3].
• The company swung to a profit in Q3 2026 and raised its full-year 2026 outlook, indicating improved financial performance [N4].
• Q3 earnings showed strength driven by organic growth across key segments [N1].
• DuPont's Q3 earnings metrics were analyzed in detail, highlighting operational execution [N2].
• The company completed the Aramids business divestiture in April 2026, receiving cash proceeds and equity interests [S2].
• DuPont maintains a strong liquidity position with $1.65 billion in cash and cash equivalents and a current ratio of 2.36 as of September 30, 2026 [S2].
• The company continues to manage supply chain risks amid geopolitical tensions, including the Middle East conflict [S2].

DuPont's strategic focus on high-value specialty chemicals and advanced solutions positions it to serve growing markets in healthcare and water technologies. Recent acquisitions expand its product offerings and geographic footprint, potentially enhancing revenue streams. The company's strong liquidity and capital management provide financial flexibility to support innovation and operational improvements. Effective risk management, including cybersecurity and supply chain diversification, may help mitigate external disruptions. Continued execution on these fronts could sustain operational profitability and support business stability.

DuPont faces risks from global supply chain disruptions, geopolitical conflicts, and volatile raw material and energy costs, which could adversely impact sales, margins, and liquidity. The company's exposure to complex international markets and reliance on third-party suppliers may lead to operational challenges. Potential impairments of goodwill or other assets and the impact of regulatory changes could affect financial results. Despite mitigation efforts, sustained adverse economic conditions or disruptions could negatively influence the company's business performance and financial condition.

DuPont's moat is supported by its diversified portfolio of specialty chemical products and advanced solutions tailored to critical markets such as healthcare and water technologies. The company's innovation-driven approach, combined with strategic acquisitions and divestitures, enhances its technological capabilities and market reach. Long-term supplier relationships, proprietary technologies, and regulatory compliance contribute to competitive advantages. Additionally, DuPont's scale and global presence enable operational efficiencies and resilience against supply chain disruptions. The company's active management of capital structure and liquidity further supports its ability to invest in growth and navigate market challenges.

• Supply Chain and Operational Disruptions: DuPont's operations depend on the availability of energy, raw materials, and third-party suppliers. Disruptions due to geopolitical conflicts, natural disasters, labor shortages, or pandemics could increase costs, reduce sales, and impact liquidity.
• Geopolitical and Economic Uncertainty: Military conflicts such as those in the Middle East and related governmental actions may cause volatility in energy markets and logistics, affecting DuPont's ability to meet customer demand and maintain financial stability.
• Cybersecurity Risks: Cybersecurity is a material risk managed by experienced executives and overseen by the Board. Cyber incidents could impact internal controls and operational continuity.
• Market and Competitive Risks: Competitive pressures and economic conditions influence DuPont's ability to pass on higher raw material costs through price increases, affecting profitability.
• Financial Risks: Potential impairments, restructuring costs, and the impact of share repurchase excise taxes could affect financial results and capital allocation.

• DuPont de Nemours Inc operates in the Basic Materials sector, specifically in Specialty Chemicals.
• The company completed the separation of its semiconductor and interconnect solutions businesses into an independent public company named Qnity Electronics, Inc. on November 1, 2025; these results are reported as discontinued operations.
• DuPont completed the sale of its Aramids business on April 1, 2026, receiving cash proceeds, a note receivable, and a non-controlling equity interest; this business is reported as discontinued operations.
• The company realigned its reporting segments in 2025, currently reporting two segments: Healthcare & Water Technologies and Diversified Industrials.
• Recent acquisitions include Sinochem (reverse osmosis manufacturer in China) in October 2025, Donatelle Plastics (medical device company) in July 2024, and Spectrum Plastics Group in August 2023.
• DuPont has a history of share repurchase programs, including a $2 billion authorization approved in late 2025 and executed accelerated share repurchases.
• The company maintains liquidity with $1.65 billion in cash and cash equivalents and a current ratio of 2.36 as of September 30, 2026.
• Q3 2026 net sales were reported at $1.9 billion.
• Q3 2026 net income was $123 million with basic EPS of $0.92 and diluted EPS of $0.91.
• The company reported a swing to profit in Q3 2026 and raised its full-year 2026 outlook.
• DuPont faces risks related to supply chain and operational disruptions, including geopolitical conflicts such as the Middle East military conflict, which could impact costs, sales, and liquidity.
• The company manages cybersecurity risks with oversight by the Board and dedicated executives with relevant experience and credentials.
• DuPont's liquidity position as of September 30, 2026, includes $4.74 billion in current assets and $2.01 billion in current liabilities, supporting financial flexibility.
• The company uses long-term contracts and multiple suppliers to mitigate supply chain risks and price fluctuations.
• DuPont's business includes advanced solutions for healthcare, water, construction, and industrial markets, focusing on innovation and technology pipelines.
• The company pays quarterly dividends and has a history of managing capital structure through debt repayments and share repurchases.